‌

US Patent 7303746 Methods of treating eye disorders with modified chimeric polypeptides

Patent 7303746 was granted and assigned to Regeneron Pharmaceuticals, Inc. on December, 2007 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

George D. Yancopoulos0

Nicholas Papadopoulos0

Stanley J. Wiegand0

Date of Patent

December 4, 2007

0

Patent Application Number

109882430

Date Filed

November 12, 2004

0

Patent Citations Received

US Patent 12116622 Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF

0

0

0

0

US Patent 12070502 Process for reducing subvisible particles in a pharmaceutical formulation

0

US Patent 12077570 Anti-VEGF protein compositions and methods for producing the same

0

US Patent 12103960 VEGF traps and mini-traps and methods for treating ocular disorders and cancer

0

US Patent 11707506 Use of a VEGF antagonist to treat angiogenic eye disorders

0

...

Patent Primary Examiner

Christine J. Saoud

0

Patent abstract

Modified chimeric polypeptides with improved pharmacokinetics are disclosed useful for treating eye disorders, including age-related macular degeneration and diabetic retinopathy.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7303746 Methods of treating eye disorders with modified chimeric polypeptides

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.